Delivery Order SPE2DB22D3016-SPE2DB24FAQG3

Award Date 3/18/24
Potential Completion Date 4/8/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,383.74 firm fixed-price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty medication, with a completion date of December 18, 2024. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,103.66 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of March 8, 2024 and was awarded on February 15, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,310.92 firm fixed-price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $25,585.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with a performance period through June 4, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award, valued at $17,056.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with AmerisourceBergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, a delivery order contract worth $35,965.17 for the supply of 400 mg/20 ml vials of the medication VYVGART. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of medical supplies, including the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The $12,792.51 firm-fixed-price delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which enables the company to supply a wide range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of VYVGART 400 MG/20 ML VIAL 20ML. The contract is a firm fixed-price delivery order with a ceiling value of $25,585.02 and a period of performance ending on July 17, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAQG3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,207.28 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product.

The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 6/17/24, 9:20 AM